Acupuncture for mild cognitive impairment: rubbish in, rubbish out

10920514_e45b497201_o

Edzard Ernst shines a light on the unfounded claims presented in a meta-analysis published today on acupuncture for amnestic mild cognitive impairment.

[read the full story...]

Cognitive tests for dementia: MMSE, Mini-Cog and ACE-R

7158418_2215ef4a6e_b

Akshay Nair explores the results of a systematic review of cognitive tests for dementia and mild cognitive impairment, which focuses on the MMSE, Mini-Cog, ACE-R and MoCA instruments. Along the way he explains how diagnostic tests work and how sensitivity and specificity are useful measures to get your head around.

[read the full story...]

Psychotherapies for depression and anxiety in dementia

The study highlighted a lack of evidence about what CMHT services work for older people.

Clarissa Giebel summarises a recent systematic review that investigates the effectiveness of various psychotherapies (CBT, interpersonal therapy, counselling) for depression and anxiety in people with dementia or mild cognitive impairment.

[read the full story...]

Dementia risk factors in people with mild cognitive impairment

People with a learning disability and family carers are able to talk about end-of-life care and healthcare professionals need to acknowledge and respect this expertise

Akshay Nair summarises a recent systematic review and meta-analysis of modifiable predictors of dementia in mild cognitive impairment. The meta-analysis finds that diabetes and the presence of any neuropsychiatric symptoms significantly predicted the conversion of mild cognitive impairment to dementia.

[read the full story...]

Cognitive and exercise interventions for older adults with and without cognitive impairment

Jake Crawshaw reports on a recent systematic review of cognitive and exercise interventions for older people with and without cognitive impairment.

[read the full story...]

Dementia and the drive to increase diagnosis rates: the debate goes on

shutterstock_135636785

As part of its excellent ‘Too Much Medicine’ series, the British Medical Journal last week published an important analysis of the current direction of travel in the field of dementia care. The article is hard to ignore, written as it is by highly authoritative academics from the UK and Australia, including Professor Carol Brayne, an [read the full story…]

Intensive cognitive training may help to prevent cognitive decline

Brain exercising with weights

Cognitive decline describes increasing problems with memory, comprehension, language and mental agility. Mild cognitive impairment means that a person has cognitive decline beyond that which might be expected for their age, but generally do not experience problems with everyday living (Alzheimer’s Society, 2012). Dementia has similar symptoms, but these are more severe and people with [read the full story…]

Short-term recovery from mild cognitive impairment is possible, but an increased risk of further cognitive decline remains

Dementia

The symptoms of mild cognitive impairment (MCI) include problems with cognitive functioning such as day-to-day memory. In some individuals it is the first sign of dementia, whereas in others it may be due to resolvable factors such as being the side-effect of medication (Alzheimer’s Society, 2012). At present it is unclear how many people with [read the full story…]

New Cochrane review says that vitamin E should not be used to treat dementia

shutterstock_109104293

It was relatively recently that every Tom, Dick and Harry in the scientific community was popping vitamin E supplements in the hope that this antioxidant would help protect them from the damaging effects of free radicals. Us elves get our vitamin E from the vegetables, fruits and whole grains that make up our naturally healthy diet. Many single [read the full story…]

Cholinesterase inhibitors should not be recommended for mild cognitive impairment, says Cochrane review

shutterstock_16791478

Early diagnosis and effective treatment of dementia will help large numbers of the population remain independent for longer. Cholinesterase inhibitors are one of the anti-dementia drugs that are used to treat Alzheimer’s disease, and they are often used immediately after diagnosis. This new systematic review from the Cochrane Dementia and Cognitive Improvement Group, looks at [read the full story…]